US Congress Senate Bill 551 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on February 25 2019 - 25% progression, died in committee
Action: 2019-02-25 - Read twice and referred to the Committee on Finance. (text: CR S1439)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties. The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)

REFUND Act of 2019 Recovering Excessive Funds for Unused and Needless Drugs Act of 2019

Sen. Richard Durbin [D-IL]	Sen. Rob Portman [R-OH]	Sen. Michael Bennet [D-CO]	Sen. Sherrod Brown [D-OH]
Sen. Mike Braun [R-IN]

Date	Chamber	Action
2019-02-25	Senate	Read twice and referred to the Committee on Finance. (text: CR S1439)

HB4178 (Same As) 2019-08-12 - Referred to the Subcommittee on Health.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/551/all-info
Text	https://www.congress.gov/116/bills/s551/BILLS-116s551is.pdf